Comparison of biological properties of umbilical cord‑derived mesenchymal stem cells from early and late passages: Immunomodulatory ability is enhanced in aged cells

Zhuang,Yong; Li,Dong; Fu,Jinqiu; Shi,Qing; Lu,Yuanyuan; Ju,Xiuli

doi:10.3892/mmr.2014.2755

Comparison of biological properties of umbilical cord‑derived mesenchymal stem cells from early and late passages: Immunomodulatory ability is enhanced in aged cells

Authors:
- Yong Zhuang
- Dong Li
- Jinqiu Fu
- Qing Shi
- Yuanyuan Lu
- Xiuli Ju
View Affiliations

Affiliations: Department of Pediatrics, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China, Cryomedicine Laboratory, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China
Published online on: October 23, 2014 https://doi.org/10.3892/mmr.2014.2755
Pages: 166-174
Copyright: © Zhuang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mesenchymal stem cells (MSCs) are a potential source of adult stem cells for cell‑based therapeutics due to their substantial multilineage differentiation capacity and secretory functions. No information is presently available regarding the maintenance of immunosuppressive properties of this cell type with repeated passages. It was therefore the aim of the present study to analyze the biological properties, particularly the immunoregulatory effect, of MSCs from late passages. The differences between young and old MSCs in morphology, cell surface antigen phenotype, proliferation, gene expression and immunomodulatory ability were investigated. The results of the current study demonstrated that with the passage of cells, senescent MSCs displayed a characteristically enlarged and flattened morphology, different gene expression profiles and stronger immunosuppressive activities. Increased interleukin‑6 production may be a possible underlying mechanism for this enhanced immunomodulatory ability of MSCs. These findings suggest that aged MSCs may provide a treatment option for patients with graft versus host disease and other diseases associated with dysregulation of the immune system.

View Figures

View References

1	Williams AR and Hare JM: Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 109:923–940. 2011. View Article : Google Scholar
2	Musumeci G, Lo Furno D, Loreto C, et al: Mesenchymal stem cells from adipose tissue which have been differentiated into chondrocytes in three-dimensional culture express lubricin. Exp Biol Med (Maywood). 236:1333–1341. 2011. View Article : Google Scholar : PubMed/NCBI
3	Matsushita K, Morello F, Wu Y, et al: Mesenchymal stem cells differentiate into renin-producing juxtaglomerular (JG)-like cells under the control of liver X receptor-alpha. J Biol Chem. 285:11974–11982. 2010. View Article : Google Scholar : PubMed/NCBI
4	Johnson TV, Bull ND, Hunt DP, et al: Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Invest Ophthalmol Vis Sci. 51:2051–2059. 2010. View Article : Google Scholar : PubMed/NCBI
5	Weiss ML, Medicetty S, Bledsoe AR, et al: Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson’s disease. Stem Cells. 24:781–792. 2006.PubMed/NCBI
6	Tsai PC, Fu TW, Chen YM, et al: The therapeutic potential of human umbilical mesenchymal stem cells from Wharton’s jelly in the treatment of rat liver fibrosis. Liver Transpl. 15:484–495. 2009.
7	Lund RD, Wang S, Lu B, et al: Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells. 25:602–611. 2007. View Article : Google Scholar : PubMed/NCBI
8	Liao W, Xie J, Zhong J, et al: Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation. 87:350–359. 2009. View Article : Google Scholar : PubMed/NCBI
9	Boregowda SV and Phinney DG: Therapeutic applications of mesenchymal stem cells: current outlook. BioDrugs. 26:201–208. 2012. View Article : Google Scholar : PubMed/NCBI
10	Atoui R, Shum-Tim D and Chiu RC: Myocardial regenerative therapy: immunologic basis for the potential ‘universal donor cells’. Ann Thorac Surg. 86:327–334. 2008.PubMed/NCBI
11	Aggarwal S and Pittenger MF: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 105:1815–1822. 2005. View Article : Google Scholar : PubMed/NCBI
12	Chen YT, Sun CK, Lin YC, et al: Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med. 9:512011. View Article : Google Scholar
13	Subbanna PK: Mesenchymal stem cells for treating GVHD: in-vivo fate and optimal dose. Med Hypotheses. 69:469–470. 2007. View Article : Google Scholar : PubMed/NCBI
14	Laschober GT, Brunauer R, Jamnig A, et al: Age-specific changes of mesenchymal stem cells are paralleled by upregulation of CD106 expression as a response to an inflammatory environment. Rejuvenation Res. 14:119–131. 2011. View Article : Google Scholar : PubMed/NCBI
15	Lee OK, Kuo TK, Chen WM, et al: Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood. 103:1669–1675. 2004. View Article : Google Scholar : PubMed/NCBI
16	Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
17	Li J, Li D, Liu X, Tang S and Wei F: Human umbilical cord mesenchymal stem cells reduce systemic inflammation and attenuate LPS-induced acute lung injury in rats. J Inflamm (Lond). 9:332012. View Article : Google Scholar : PubMed/NCBI
18	Justesen J, Stenderup K, Eriksen EF and Kassem M: Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int. 71:36–44. 2002. View Article : Google Scholar : PubMed/NCBI
19	Stenderup K, Justesen J, Clausen C and Kassem M: Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 33:919–926. 2003. View Article : Google Scholar : PubMed/NCBI
20	Tokalov SV, Gruener S, Schindler S, et al: A number of bone marrow mesenchymal stem cells but neither phenotype nor differentiation capacities changes with age of rats. Mol Cells. 24:255–260. 2007.PubMed/NCBI
21	von Zglinicki T and Martin-Ruiz CM: Telomeres as biomarkers for ageing and age-related diseases. Curr Mol Med. 5:197–203. 2005.
22	Olovnikov AM: A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol. 41:181–190. 1973.PubMed/NCBI
23	Hayflick L: Mortality and immortality at the cellular level. A review. Biochemistry (Mosc). 62:1180–1190. 1997.PubMed/NCBI
24	Campisi J and d‘Adda di Fagagna F: Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 8:729–740. 2007. View Article : Google Scholar : PubMed/NCBI
25	Toussaint O, Medrano EE and von Zglinicki T: Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp Gerontol. 35:927–945. 2000. View Article : Google Scholar : PubMed/NCBI
26	Serrano M and Blasco MA: Putting the stress on senescence. Curr Opin Cell Biol. 13:748–753. 2001. View Article : Google Scholar : PubMed/NCBI
27	Banfi A, Muraglia A, Dozin B, et al: Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol. 28:707–715. 2000. View Article : Google Scholar : PubMed/NCBI
28	Baxter MA, Wynn RF, Jowitt SN, et al: Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells. 22:675–682. 2004. View Article : Google Scholar : PubMed/NCBI
29	Hall A and Nobes CD: Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton. Philos Trans R Soc Lond B Biol Sci. 355:965–970. 2000. View Article : Google Scholar : PubMed/NCBI
30	Kao G, Huang CC, Hedgecock EM, Hall DH and Wadsworth WG: The role of the laminin beta subunit in laminin heterotrimer assembly and basement membrane function and development in C elegans. Dev Biol. 290:211–219. 2006. View Article : Google Scholar : PubMed/NCBI
31	Kadler KE, Hill A and Canty-Laird EG: Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol. 20:495–501. 2008. View Article : Google Scholar : PubMed/NCBI
32	Meisel R, Zibert A, Laryea M, et al: Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood. 103:4619–4621. 2004. View Article : Google Scholar : PubMed/NCBI
33	Sato K, Ozaki K, Oh I, et al: Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood. 109:228–234. 2007. View Article : Google Scholar : PubMed/NCBI
34	Batten P, Sarathchandra P, Antoniw JW, et al: Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng. 12:2263–2273. 2006. View Article : Google Scholar : PubMed/NCBI
35	Groh ME, Maitra B, Szekely E and Koç ON: Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol. 33:928–934. 2005. View Article : Google Scholar : PubMed/NCBI
36	Bunnell BA, Betancourt AM and Sullivan DE: New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Res Ther. 1:342010. View Article : Google Scholar : PubMed/NCBI
37	Zhang Q, Shi S, Liu Y, et al: Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol. 183:7787–7798. 2009. View Article : Google Scholar
38	Niedbala W, Cai B and Liew FY: Role of nitric oxide in the regulation of T cell functions. Ann Rheum Dis. 65(Suppl 3): iii37–iii40. 2006. View Article : Google Scholar : PubMed/NCBI
39	Couper KN, Blount DG and Riley EM: IL-10: the master regulator of immunity to infection. J Immunol. 180:5771–5777. 2008. View Article : Google Scholar : PubMed/NCBI
40	Otterbein LE and Choi AM: Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol. 279:L1029–1037. 2000.PubMed/NCBI
41	Chauveau C, Rémy S, Royer PJ, et al: Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood. 106:1694–1702. 2005. View Article : Google Scholar : PubMed/NCBI
42	Chabannes D, Hill M, Merieau E, et al: A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood. 110:3691–3694. 2007. View Article : Google Scholar : PubMed/NCBI
43	Bach FH: Heme oxygenase-1: a therapeutic amplification funnel. FASEB J. 19:1216–1219. 2005. View Article : Google Scholar : PubMed/NCBI
44	Toussaint O, Remacle J, Dierick JF, et al: From the Hayflick mosaic to the mosaics of ageing. Role of stress-induced premature senescence in human ageing. Int J Biochem Cell Biol. 34:1415–1429. 2002. View Article : Google Scholar : PubMed/NCBI
45	Derynck R, Akhurst RJ and Balmain A: TGF-beta signaling in tumor suppression and cancer progression. Nat Genet. 29:117–129. 2001. View Article : Google Scholar : PubMed/NCBI
46	Djouad F, Charbonnier LM, Bouffi C, et al: Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells. 25:2025–2032. 2007. View Article : Google Scholar : PubMed/NCBI
47	Singh T and Newman AB: Inflammatory markers in population studies of aging. Ageing Res Rev. 10:319–329. 2011. View Article : Google Scholar : PubMed/NCBI
48	Ryu E, Hong S, Kang J, et al: Identification of senescence-associated genes in human bone marrow mesenchymal stem cells. Biochem Biophys Res Commun. 371:431–436. 2008. View Article : Google Scholar : PubMed/NCBI
49	Zhan Q, Lord KA, Alamo I Jr, et al: The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol. 14:2361–2371. 1994. View Article : Google Scholar : PubMed/NCBI